A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.
Key Details
- 1Study reviewed FDA data for AI/ML devices cleared between 1995 and July 2023.
- 2Out of 691 devices analyzed, 531 were radiology-specific.
- 3Fewer than 30% of devices shared safety or adverse event information prior to clearance.
- 4Authors call for more stringent testing and clearer regulatory standards.
- 5Lack of predefined efficacy and risk standards highlighted as a critical issue.
Why It Matters
Radiology relies heavily on AI devices, making their safety and efficacy crucial to patient care. The study urges tighter oversight and transparency, which could directly impact how radiologists incorporate AI into practice.
Source
Health Imaging
Related News
•AuntMinnie
AI’s Path in Radiology Hinges on Tech, Policy, and Human Insight
SIIM-CAIMI keynote highlights that AI's future in radiology depends on synchronized advances in technology, regulation, finance, and culture.
•Radiology Business
Meta Funds Ohio State’s Radiology AI Innovation Projects
Meta will fund Ohio State researchers to explore AI-driven advancements in radiology, including chest X-ray reporting and disease prediction.
•AuntMinnie
SIIM-CAIMI Leaders Discuss Key Trends in Imaging AI Deployment
SIIM-CAIMI program chairs highlight AI's transition from algorithm evaluation to real-world implementation in medical imaging.